Lumateperone as an alternative to clozapine in treatment-resistant schizophrenia: Insights from a quantitative systems pharmacology model
J Pharmacol Exp Ther. 2026 May 14;393(7):104944. doi: 10.1016/j.jpet.2026.104944. Online ahead of print.ABSTRACTClozapine remains the only drug with superior efficacy in treatment-resistant schizophrenia (TRS) but...
